scholarly journals Long-term Survival of Children with Human Immunodeficiency Virus Infectin in New York: City: Estimates from Population-based Surveillance Data

1998 ◽  
Vol 147 (9) ◽  
pp. 846-854 ◽  
Author(s):  
L. Kuhn ◽  
P. A. Thomas ◽  
T. Singh ◽  
W.-Y. Tsai
2015 ◽  
Vol 2 (4) ◽  
Author(s):  
Chitra Ramaswamy ◽  
Tanya M. Ellman ◽  
Julie Myers ◽  
Ann Madsen ◽  
Kent Sepkowitz ◽  
...  

Abstract Background.  Studying the most extreme example of late diagnosis, new HIV diagnoses after death, may be instructive to HIV testing efforts. Using the results of routine HIV testing of autopsies performed by the Office of Chief Medical Examiner (OCME), we identified new HIV diagnoses after death in New York City (NYC) from 2008 to 2012. Methods.  Population-based registries for HIV and deaths were linked to identify decedents not known to be HIV-infected before death. Multivariable logistic regression models were constructed to determine correlates of a new HIV diagnosis after death among all persons newly diagnosed with HIV and among all HIV-infected decedents receiving an OCME autopsy. Results.  Of 264 893 deaths, 24 426 (9.2%) were autopsied by the NYC OCME. Of these, 1623 (6.6%) were infected with HIV, including 142 (8.8%) with a new HIV diagnosis at autopsy. This represents 0.8% (142 of 18 542) of all new HIV diagnoses during the 5-year period. Decedents newly diagnosed with HIV at OCME autopsy were predominantly male (73.9%), aged 13–64 years (85.9%), non-white (85.2%), unmarried (81.7%), less than college educated (83.8%), and residents of an impoverished neighborhood (62.0%). Of all HIV-infected OCME decedents aged ≥65 years (n = 71), 22.0% were diagnosed at autopsy. The strongest independent correlate of new HIV diagnosis at autopsy in both multivariable models was age ≥65 years. Conclusions.  Human immunodeficiency virus diagnoses first made after death are rare, but, when observed, these diagnoses are more commonly found among persons ≥65 years, suggesting that despite highly visible efforts to promote HIV testing community-wide, timely diagnosis among older adults living in impoverished, high-prevalence neighborhoods may require additional strategies.


1989 ◽  
Vol 29 (3) ◽  
pp. 181-185 ◽  
Author(s):  
David M. Novick ◽  
Harold L. Trigg ◽  
Don C. Des Jarlais ◽  
Samuel R. Friedman ◽  
David Vlahov ◽  
...  

2020 ◽  
Vol 71 (11) ◽  
pp. 2933-2938 ◽  
Author(s):  
Keith Sigel ◽  
Talia Swartz ◽  
Eddye Golden ◽  
Ishan Paranjpe ◽  
Sulaiman Somani ◽  
...  

Abstract Background There are limited data regarding the clinical impact of coronavirus disease 2019 (COVID-19) on people living with human immunodeficiency virus (PLWH). In this study, we compared outcomes for PLWH with COVID-19 to a matched comparison group. Methods We identified 88 PLWH hospitalized with laboratory-confirmed COVID-19 in our hospital system in New York City between 12 March and 23 April 2020. We collected data on baseline clinical characteristics, laboratory values, HIV status, treatment, and outcomes from this group and matched comparators (1 PLWH to up to 5 patients by age, sex, race/ethnicity, and calendar week of infection). We compared clinical characteristics and outcomes (death, mechanical ventilation, hospital discharge) for these groups, as well as cumulative incidence of death by HIV status. Results Patients did not differ significantly by HIV status by age, sex, or race/ethnicity due to the matching algorithm. PLWH hospitalized with COVID-19 had high proportions of HIV virologic control on antiretroviral therapy. PLWH had greater proportions of smoking (P < .001) and comorbid illness than uninfected comparators. There was no difference in COVID-19 severity on admission by HIV status (P = .15). Poor outcomes for hospitalized PLWH were frequent but similar to proportions in comparators; 18% required mechanical ventilation and 21% died during follow-up (compared with 23% and 20%, respectively). There was similar cumulative incidence of death over time by HIV status (P = .94). Conclusions We found no differences in adverse outcomes associated with HIV infection for hospitalized COVID-19 patients compared with a demographically similar patient group.


1999 ◽  
Vol 94 (5, Part 1) ◽  
pp. 647-652
Author(s):  
MARGARET POLANECZKY ◽  
MICHELLE CADOGAN ◽  
KATHLEEN MCGUINNESS ◽  
MELISSA WATERSTONE

2006 ◽  
Vol 40 (5) ◽  
pp. 385-390 ◽  
Author(s):  
Allen Ahdoot ◽  
Donald P. Kotler ◽  
Jin S. Suh ◽  
Charles Kutler ◽  
Rachel Flamholz

Sign in / Sign up

Export Citation Format

Share Document